Market Research Logo

Biomarkers Market by Product (Consumables, Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Disorders), Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - Global Forecast to 2021

Biomarkers Market by Product (Consumables, Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Disorders), Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - Global Forecast to 2021

The global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.
Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research are the major factors driving the growth of the global biomarkers market. In recent years, the Asian biomarkers market has witnessed significant growth due to the increasing use of biomarkers for diagnostic purposes, increasing incidence of chronic diseases, and increasing outsourcing of pharmaceutical R&D activities to outsourcing partners in Asia.

In this report, the global biomarkers market is segmented on the basis of product, type, application, disease indication, and region. On the basis of product, the biomarkers market is segmented into consumables, services, and software. The consumables segment is estimated to account for the largest share of the global biomarkers market in 2016. The large share can primarily be attributed to the lower price of consumables than that of screening and automation instruments.

On the basis of type, the biomarkers market is segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. The efficacy biomarkers segment if further segmented into predictive biomarkers, surrogate biomarkers, pharmacodynamic biomarkers, and prognostic biomarkers. The safety biomarkers segment is estimated to account for the largest share in 2016. This is due to their widespread applications in drug discovery and development.

On the basis of application, the biomarkers market is categorized into diagnostics, drug discovery & development, personalized medicine, disease risk assessment, and other applications (DNA fingerprinting, ecotoxicology, and forensics). The diagnostics segment is estimated to account for the largest share of the market in 2016. Factors such as increasing prevalence of cancer, technologically developed biomarker products, individualized treatments for cancer, and the need for early-stage cancer diagnosis are driving the growth of this segment in the biomarkers market.

On the basis of disease indication, the biomarkers market is categorized into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others (renal disorders, urinal diseases, diabetes, and tuberculosis). The cancer segment is estimated to account for the largest share of the biomarkers market in 2016. This is primarily attributed to the increasing prevalence of cancer. The use of cancer biomarkers provides great opportunities for improving the management of cancer patients by enhancing detection and efficacy of treatment.

New product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the biomarkers market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the biomarkers market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on products offered by the top players in the biomarkers market
Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the biomarkers market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for biomarker products across various regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the biomarkers market
Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the biomarkers market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED IN THE REPORT
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
    • MARKET RANK ESTIMATION
    • KEY INDUSTRY INSIGHTS
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • BIOMARKERS: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: BIOMARKERS MARKET, BY PRODUCT (2016)
    • BIOMARKERS MARKET, BY TYPE, 2016 VS. 2021
    • BIOMARKERS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
    • BIOMARKERS MARKET, BY DISEASE INDICATION, 2016 VS. 2021
    • BIOMARKERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • LIFE CYCLE ANALYSIS, BY REGION, 2016
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table LIST OF FDA-APPROVED BIOMARKERS FOR DIFFERENT TYPES OF CANCER
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • BIOMARKERS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • CONSUMABLES
      • Table BIOMARKER CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKER CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKER CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • SERVICES
      • Table BIOMARKER SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKER SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKER SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • SOFTWARE
      • Table BIOMARKER SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKER SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKER SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • BIOMARKERS MARKET, BY TYPE
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • SAFETY BIOMARKERS
      • Table SAFETY BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: SAFETY BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: SAFETY BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • EFFICACY BIOMARKERS
      • Table EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table EFFICACY BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: EFFICACY BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: EFFICACY BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • PREDICTIVE BIOMARKERS
        • Table PREDICTIVE BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
        • Table NORTH AMERICA: PREDICTIVE BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • SURROGATE BIOMARKERS
        • Table SURROGATE BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
        • Table NORTH AMERICA: SURROGATE BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • PHARMACODYNAMIC BIOMARKERS
        • Table PHARMACODYNAMIC BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
        • Table NORTH AMERICA: PHARMACODYNAMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • PROGNOSTIC BIOMARKERS
        • Table PROGNOSTIC BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
        • Table NORTH AMERICA: PROGNOSTIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • VALIDATION BIOMARKERS
      • Table VALIDATION BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: VALIDATION BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: VALIDATION BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • BIOMARKERS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • DIAGNOSTICS
      • Table BIOMARKERS MARKET SIZE FOR DIAGNOSTICS DEVELOPMENT, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR DIAGNOSTICS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR DIAGNOSTICS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD BILLION)
    • DRUG DISCOVERY AND DEVELOPMENT
      • Table BIOMARKERS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2014-2021 (USD BILLION)
    • PERSONALIZED MEDICINE
      • Table BIOMARKERS MARKET SIZE FOR PERSONALIZED MEDICINE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR PERSONALIZED MEDICINE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR PERSONALIZED MEDICINE, BY COUNTRY, 2014-2021 (USD BILLION)
    • DISEASE RISK ASSESSMENT
      • Table BIOMARKERS MARKET SIZE FOR DISEASE RISK ASSESSMENT, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR DISEASE RISK ASSESSMENT, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR DISEASE RISK ASSESSMENT, BY COUNTRY, 2014-2021 (USD BILLION)
    • OTHER APPLICATIONS
      • Table BIOMARKERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • BIOMARKERS MARKET, BY DISEASE INDICATION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
    • CANCER
      • Table KEY CANCER BIOMARKERS IN CLINICAL USE
      • Table BIOMARKERS MARKET SIZE FOR CANCER, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR CANCER, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR CANCER, BY COUNTRY, 2014-2021 (USD BILLION)
    • CARDIOVASCULAR DISORDERS
      • Table BIOMARKERS FOR CARDIOVASCULAR DISORDER
      • Table BIOMARKERS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION/COUNTRY, 2014-2021 (USD BILLION)
    • NEUROLOGICAL DISORDERS
      • Table BIOMARKERS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION/COUNTRY, 2014-2021 (USD BILLION)
    • IMMUNOLOGICAL DISORDERS
      • Table BIOMARKERS FOR IMMUNOLOGICAL DISORDERS
      • Table BIOMARKERS MARKET SIZE FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR IMMUNOLOGICAL DISORDERS, BY REGION/COUNTRY, 2014-2021 (USD BILLION)
    • OTHER DISEASES
      • Table BIOMARKERS FOR RENAL DISORDERS
      • Table BIOMARKERS MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE FOR OTHER DISEASES, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE FOR OTHER DISEASES, BY COUNTRY, 2014-2021 (USD BILLION)
  • BIOMARKERS MARKET, BY REGION
    • INTRODUCTION
      • Table BIOMARKERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
      • U.S.
        • Table U.S.: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table U.S.: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table U.S.: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
      • CANADA
        • Table CANADA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table CANADA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table CANADA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
    • EUROPE
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table EUROPE: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table EUROPE: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
    • ASIA
      • Table ASIA: BIOMARKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ASIA: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ASIA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
      • CHINA
        • Table CHINA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table CHINA: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table CHINA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table CHINA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
      • JAPAN
        • Table JAPAN: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table JAPAN: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table JAPAN: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table JAPAN: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
      • REST OF ASIA
        • Table REST OF ASIA: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table REST OF ASIA: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
        • Table REST OF ASIA: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table REST OF ASIA: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: BIOMARKERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ROW: EFFICACY BIOMARKERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ROW: BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • Table BATTLE FOR MARKET SHARE: PRODUCT LAUNCH WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS IN BIOMARKERS MARKET BETWEEN 2014 AND 2016
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2014-2016
      • COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
        • Table COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2014-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2014-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2014-2016
    • LEADING PLAYERS IN THE BIOMARKERS MARKET
      • Table RANK OF COMPANIES IN THE BIOMARKERS MARKET, 2016
  • COMPANY PROFILES
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PERKINELMER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK MILLIPORE
      • BUSINESS OVERVIEW
      • PRODUCT & SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ENZO BIOCHEM, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • EKF DIAGNOSTICS HOLDINGS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERED
      • RECENT DEVELOPMENTS
    • MESO SCALE DIAGNOSTICS, LLC.
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • BIOSIMS TECHNOLOGIES SAS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • CISBIO BIOASSAYS
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • SIGNOSIS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report